Czechia, Oct. 17 -- Czechia based GlaxoSmithKline, s.r.o. has secured contract from Fakultni nemocnice Olomouc for Antineoplastic agents - LP CONTAINING DOSTARLIMABU 2025. The value of the contract is worth 1203587010 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....